|
|
Article: Epirubicin, vinorelbine, and cisplatin are effective in advanced breast cancer.
- Article from:
- Drug Week
- Article date:
- April 9, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 APR 9 - (NewsRx.com & NewsRx.net) -- Combined epirubicin, vinorelbine, and cisplatin resulted in an 84% objective response rate for patients with advanced breast cancer.
"Our objective was to evaluate the activity and safety of the combination of cisplatin, epirubicin and vinorelbine (CEV) in advanced breast cancer patients. Patients with advanced breast cancer, locally advanced or metastatic, received epirubicin 75 mg/m[superscript]2 and cisplatin 50 mg/m[superscript]2 on day 1, and vinorelbine 25 mg/m[superscript]2 on day 5. Cycles were repeated every 3 weeks," investigators in Italy report.
"A total of 35 patients were treated. Thirty-one ...